HIGHLIGHTS
- who: Eugenia Accorsi Buttini and collaborators from the Almoosa Specialist Hospital, Saudi Arabia Nanjing Medical University, China have published the Article: High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review, in the Journal: (JOURNAL)
- what: The authors report the first case of high risk (HR)-MDS with chromosome 7 deletion and RUNX1 mutation, which developed after CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma (DLBCL).
SUMMARY
Two months after . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.